SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-15-161923
Filing Date
2015-04-30
Accepted
2015-04-30 16:15:55
Documents
16
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d913483d10q.htm 10-Q 419261
2 EX-10.1 d913483dex101.htm EX-10.1 261069
3 EX-10.2 d913483dex102.htm EX-10.2 548064
4 EX-10.3 d913483dex103.htm EX-10.3 37858
5 EX-31.1 d913483dex311.htm EX-31.1 7481
6 EX-31.2 d913483dex312.htm EX-31.2 7362
7 EX-32.1 d913483dex321.htm EX-32.1 4173
14 GRAPHIC g913483g10l62.jpg GRAPHIC 6390
15 GRAPHIC g913483g29e94.jpg GRAPHIC 5547
16 GRAPHIC g913483g60c19.jpg GRAPHIC 5565
  Complete submission text file 0001193125-15-161923.txt   3699389

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT geva-20150331.xml EX-101.INS 319079
9 XBRL TAXONOMY EXTENSION SCHEMA geva-20150331.xsd EX-101.SCH 25909
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE geva-20150331_cal.xml EX-101.CAL 51464
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE geva-20150331_def.xml EX-101.DEF 68490
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE geva-20150331_lab.xml EX-101.LAB 232697
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE geva-20150331_pre.xml EX-101.PRE 155938
Mailing Address 33 HAYDEN AVE. LEXINGTON MA 02421
Business Address 33 HAYDEN AVE. LEXINGTON MA 02421 (781) 357-9900
SYNAGEVA BIOPHARMA CORP (Filer) CIK: 0000911326 (see all company filings)

IRS No.: 561808663 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-23155 | Film No.: 15818801
SIC: 2836 Biological Products, (No Diagnostic Substances)